alpha-aminopyridine has been researched along with Opportunistic Infections in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellamy, JF; Buenestado, A; Devillier, P; Faisy, C; Grassin-Delyle, S; Guitard, F; Israël-Biet, D; Naline, E; Sage, E; Tenor, H | 1 |
| Blasco, LM | 1 |
2 other study(ies) available for alpha-aminopyridine and Opportunistic Infections
| Article | Year |
|---|---|
Response to commentary: 'If roflumilast inhibits the innate immunity in the stable patient, what about infection?'.
Topics: Aminopyridines; Benzamides; Humans; Immunity, Innate; Immunocompromised Host; Opportunistic Infections | 2013 |
If roflumilast inhibits the innate immunity in the stable patient, what about infection?
Topics: Aminopyridines; Benzamides; Cyclopropanes; Humans; Immunity, Innate; Immunocompromised Host; Opportunistic Infections; Phosphodiesterase 4 Inhibitors | 2013 |